Contract Manufacturing, Sterile, Aseptic Processing

Ajinomoto Bio-Pharma Services, Humanigen in Manufacturing Agreement for COVID-19 Biologic

June 01, 2020

The companies have entered into a manufacturing agreement for the fill finish supply of lenzilumab for the potential treatment of COVID-19.

Catalent Expands Biologics Packaging Capacity

April 23, 2020

Catalent Biologics increased capacity at its Bloomington, IN Facility.

Addressing Drug Shortages

April 15, 2020

Equipment and Processing Report

Civica Rx plans redundant manufacturing capacity to relieve and prevent shortages of generic, sterile injectable drugs.

Addressing Drug Shortages

April 02, 2020

Civica Rx plans redundant manufacturing capacity to relieve and prevent shortages of generic, sterile injectable drugs.

Catalent Expands Fill-Finish Capacity

January 08, 2020

Catalent completes purchase of biologics fill-finish and oral solid dose facility in Anagni, Italy

Particle Sciences Rebrands as Lubrizol Life Science Health

November 22, 2019

Lubrizol Life Science Health adopts new name and opens commercial manufacturing facility.

Majority of High-Containment CMO Facilities Located in 5EU and Switzerland, Notes GlobalData

August 15, 2019

The latest research from GlobalData has revealed that more than two-thirds (69%) of CMOs high-containment facilities are based in the top five European Union countries and Switzerland.

Nephron and Clemson to Develop Robotics for Syringe Filling

August 15, 2019

Nephron Pharmaceuticals is partnering with Clemson University to create a robotic solution for syringe-filling automation to enhance sterile manufacturing.

The CDMO Evolution

August 02, 2019

Pharmaceutical Technology Europe

The evolution of CDMOs has led to increased investment in new technologies, capabilities, and expertise.

In Safe Hands

August 02, 2019

Pharmaceutical Technology Europe

Complex and potent molecules demand greater technical and regulatory expertise to ensure safe handling.